Annual / Quarterly Financial Statement • Mar 7, 2022
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer

Ljubljana, 4 March 2022
| EUR, except percentages | 2021 | 2020 |
|---|---|---|
| Total of all operating segments | ||
| Operating revenue | 732,714,051 | 680,801,492 |
| Year-on-year change | 7.6% | 15.5% |
| Profit or loss before tax | 93,535,270 | 67,746,714 |
| Year-on-year change | 38.1% | 11.5% |
| Profit or loss, net of tax | 76,167,178 | 56,386,299 |
| Year-on-year change | 35.1% | 12.3% |
| Comprehensive income | 57,585,416 | 75,783,096 |
| Year-on-year change | -24.0% | 27.2% |
| Return on revenue* | 10.5% | 8.6% |
| Net expense ratio, including operating revenue/** | 29.0% | 29.5% |
| Return on equity | 15.8% | 13.3% |
| Earnings or loss per share | 4.91 | 3.63 |
| Return on the investment portfolio/* | 1.8% | 1.6% |
| Reinsurance + non-life | ||
| Gross premiums written | 546,925,838 | 546,242,406 |
| Year-on-year change | 0.1% | 7.4% |
| Net incurred loss ratio* | 55.6% | 61.6% |
| Net expense ratio | 31.6% | 31.1% |
| Net combined ratio* | 88.3% | 93.9% |
| Profit or loss before tax | 72,204,759 | 41,069,220 |
| Year-on-year change | 75.8% | 1.5% |
| Life | ||
| Gross premiums written | 178,707,830 | 130,266,058 |
| Year-on-year change | 37.2% | 48.6% |
| Net expense ratio | 21.4% | 23.0% |
| Profit or loss before tax | 16,761,225 | 27,284,252 |
| Year-on-year change | -38.6% | 64.4% |
| Total of all operating segments | 31 December 2021 | 31 December 2020 |
| Total assets | 2,658,322,359 | 2,467,251,303 |
| Change on 31 December of prior year | 7.7% | 30.8% |
| Shareholders' equity | 504,077,018 | 460,214,488 |
| Change on 31 December of prior year | 9.5% | 19.6% |
| Net technical provisions | 1,703,916,399 | 1,600,307,265 |
| Change on 31 December of prior year | 6.5% | 43.4% |
| Book value per share | 32.53 | 29.70 |
| Number of employees (full-time equivalent basis) | 2,698.9 | 2,701.0 |
| Solvency ratio under Solvency II rules | 198%1 | 198% |
* Excluding the effect of exchange differences.
** Subordinated debt expenses are excluded. In 2020, impairment losses on goodwill are also excluded.
*** The amortisation charge for a customer list is excluded. The Group net expense ratio in 2020 does not include the positive difference between the fair value of net assets acquired and the purchase price of the investment in Vita.
1 The ratio is calculated using the Group's estimated eligible own funds for 2021 and the estimated SCR, both as at 31 December 2021. During the preparation of the audited annual report, the Sava Insurance Group is yet to obtain reviewed capital adequacy data for 2021 from their certified auditor. The audited annual report will include an unaudited final calculation as at 31 December 2021. An auditorreviewed annual calculation will be published in the Group's solvency and financial condition report for 2021 to be released on 20 May 2022.
| EUR | 31 December 2021 | 31 December 2020 |
|---|---|---|
| ASSETS | 2,658,322,359 | 2,467,251,303 |
| Intangible assets | 67,306,775 | 64,278,611 |
| Property, plant and equipment | 56,337,174 | 48,336,491 |
| Right-of-use assets | 7,386,426 | 8,648,594 |
| Deferred tax assets | 5,487,403 | 4,924,819 |
| Investment property | 14,281,192 | 16,121,079 |
| Financial investments in subsidiaries and associates | 20,479,729 | 15,056,143 |
| Financial investments: | 1,472,688,443 | 1,430,149,336 |
| - Loans and deposits | 29,846,572 | 31,796,178 |
| - Held to maturity | 40,023,124 | 43,679,425 |
| - Available for sale | 1,368,432,673 | 1,327,264,062 |
| - At fair value through profit or loss | 34,386,074 | 27,409,671 |
| Assets held for the benefit of policyholders who bear the investment risk | 517,439,592 | 411,224,812 |
| Reinsurers' share of technical provisions | 57,767,056 | 42,609,217 |
| Investment contract assets | 172,836,349 | 158,765,028 |
| Receivables | 149,940,870 | 153,871,498 |
| Receivables arising out of primary insurance business | 128,544,723 | 135,285,588 |
| Receivables arising out of reinsurance and co-insurance business | 9,077,165 | 6,054,576 |
| Current tax assets | 330,518 | 529,831 |
| Other receivables | 11,988,464 | 12,001,503 |
| Deferred acquisition costs | 22,572,741 | 24,278,003 |
| Other assets | 4,380,387 | 4,240,414 |
| Cash and cash equivalents | 88,647,678 | 83,458,594 |
| Non-current assets held for sale | 770,544 | 1,288,664 |
| EQUITY AND LIABILITIES | 2,658,322,359 | 2,467,251,303 |
| Shareholders' equity | 504,077,018 | 460,214,488 |
| Share capital | 71,856,376 | 71,856,376 |
| Capital reserves | 42,702,320 | 43,035,948 |
| Profit reserves | 229,008,079 | 202,285,580 |
| Own shares | -24,938,709 | -24,938,709 |
| Fair value reserve | 21,246,888 | 40,173,090 |
| Reserve due to fair value revaluation | 1,300,871 | 964,485 |
| Retained earnings | 116,166,406 | 73,413,529 |
| Net profit or loss for the period | 49,623,843 | 56,197,540 |
| Translation reserve | -3,256,354 | -3,266,013 |
| Equity attributable to owners of the controlling company | 503,709,720 | 459,721,826 |
| Non-controlling interests in equity | 367,298 | 492,662 |
| Subordinated liabilities | 74,863,524 | 74,804,974 |
| Technical provisions | 1,237,500,117 | 1,233,312,054 |
| Unearned premiums | 207,022,452 | 210,614,842 |
| Technical provisions for life insurance business | 443,577,279 | 465,641,679 |
| Provision for outstanding claims | 578,713,597 | 547,764,679 |
| Other technical provisions | 8,186,789 | 9,290,854 |
| Technical provisions for the benefit of life insurance policyholders who bear the | ||
| investment risk | 524,183,338 | 409,604,428 |
| Other provisions | 9,018,106 | 9,287,735 |
| Deferred tax liabilities | 11,387,395 | 14,901,575 |
| Investment contract liabilities | 172,660,266 | 158,596,453 |
| Other financial liabilities | 584,924 | 470,937 |
| Liabilities from operating activities | 54,783,379 | 58,412,273 |
| Liabilities from primary insurance business | 41,669,619 | 46,269,833 |
| Liabilities from reinsurance and co-insurance business | 10,109,076 | 6,837,159 |
| Current income tax liabilities | 3,004,684 | 5,305,281 |
| Lease liability | 7,224,138 | 8,255,225 |
| Other liabilities | 62,040,154 | 39,391,161 |
| EUR | ||
|---|---|---|
| 2021 | 2020 | |
| Net premiums earned | 686,574,317 | 635,361,568 |
| Gross premiums written | 729,898,408 | 679,749,305 |
| Written premiums ceded to reinsurers and co-insurers | -46,115,953 | -41,050,900 |
| Change in gross unearned premiums | 3,425,874 | -2,216,711 |
| Change in unearned premiums, reinsurers' and co-insurers' shares | -634,012 | -1,120,126 |
| Income from investments in subsidiaries and associates | 772,886 | 142,088 |
| Profit from investments in equity-accounted associate companies | 772,886 | 142,088 |
| Investment income | 34,057,270 | 26,449,203 |
| Interest income | 16,842,749 | 16,151,438 |
| Other investment income | 17,214,521 | 10,297,765 |
| Net realised and unrealised gains on investments of life insurance policyholders who bear | ||
| the investment risk | 68,719,103 | 23,043,525 |
| Other technical income | 19,101,970 | 14,544,056 |
| Commission income | 8,640,223 | 5,899,388 |
| Other technical income | 10,461,747 | 8,644,668 |
| Other income | 27,037,764 | 30,895,868 |
| Net claims incurred | -408,814,273 | -426,695,412 |
| Gross claims payments, net of income from recourse receivables | -406,908,665 | -399,532,382 |
| Reinsurers' and co-insurers' shares | 12,632,236 | 5,199,171 |
| Change in the gross provision for outstanding claims | -30,461,435 | -36,154,019 |
| Change in the provision for outstanding claims, reinsurers' and co-insurers' shares | 15,923,591 | 3,791,818 |
| Change in other technical provisions | 23,872,769 | 40,613,572 |
| Change in technical provisions for policyholders who bear the investment risk | -115,064,830 | -35,479,642 |
| Expenses for bonuses and rebates | -276,004 | -103,253 |
| Operating expenses | -219,931,765 | -203,216,146 |
| Acquisition costs | -77,684,219 | -74,410,866 |
| Change in deferred acquisition costs | -1,926,381 | 1,561,215 |
| Other operating expenses | -140,321,165 | -130,366,495 |
| Expenses for investments in subsidiaries and associates and impairment losses on | ||
| goodwill | 0 | -2,096,868 |
| Impairment loss on goodwill | 0 | -2,096,868 |
| Expenses for financial assets and liabilities | -5,710,086 | -13,122,281 |
| Impairment losses on financial assets not at fair value through profit or loss | -161,960 | -1,099,794 |
| Interest expense | -3,128,936 | -3,152,597 |
| Other investment expenses | -2,419,190 | -8,869,890 |
| Other technical expenses | -14,337,516 | -19,324,402 |
| Other expenses | -2,466,335 | -3,265,162 |
| Profit or loss before tax | 93,535,270 | 67,746,714 |
| Income tax expense | -17,368,092 | -11,360,415 |
| Net profit or loss for the period | 76,167,178 | 56,386,299 |
| Net profit or loss attributable to owners of the controlling company | 76,074,720 | 56,222,528 |
| Net profit/loss attributable to non-controlling interests | 92,457 | 163,771 |
| Earnings per share (basic and diluted) | 4.91 | 3.63 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.